http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#Head
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#assertion
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#provenance
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#pubinfo
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#assertion
http://purl.obolibrary.org/obo/DOID_11199
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_11199
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB05829
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
http://www.w3.org/2000/01/rdf-schema#label
natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin d to control hypocalcemia in patients with hypoparathyroidism limitations of use because of the potential risk of osteosarcoma natpara is recommended only for patients who cannot be well controlled on calcium supplements and active forms of vitamin d alone see warnings and precautions 5 1 natpara was not studied in patients with hypoparathyroidism caused by calcium sensing receptor mutations natpara was not studied in patients with acute post surgical hypoparathyroidism natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin d to control hypocalcemia in patients with hypoparathyroidism 1 limitations of use because of the potential risk of osteosarcoma natpara is recommended only for patients who cannot be well controlled on calcium supplements and active forms of vitamin d alone 5 1 natpara was not studied in patients with hypoparathyroidism caused by calcium sensing receptor mutations natpara was not studied in patients with acute post surgical hypoparathyroidism
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB05829
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#provenance
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#pubinfo
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig
http://purl.org/nanopub/x/hasSignature
OjEIvct5ODrMNwJHKghKR/2mt8PlSD6/Z3CTOg7eRje8iDGgIRI7dCzdB/n1K6PaSlhLdrIFxoizYTJnTPg92AN+CQYvaFvpba6Cq1WQnKGC8gaUiIjKhntp/n+yuD7E7Ttr761kItdFkdGivMKs7dn+aTbA+qMuyp0tLj5YZ0o=
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
http://purl.org/dc/terms/created
2021-07-03T14:51:17.432+02:00
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs